315x Filetype DOCX File size 0.08 MB Source: research.umn.edu
SOCIAL PROTOCOL (HRP-580)
PROTOCOL TITLE:
VERSION DATE:
INSTRUCTIONS:
● Use “SOCIAL TEMPLATE PROTOCOL (HRP-580)” to prepare a social-behavioral study
(see Investigator Manual (HRP-103) for a definition of social-behavioral research).
● For social-behavioral research involving biomedical activities, refer to the
Investigator Manual (HRP-103) for further instructions as to whether the “MEDICAL
TEMPLATE PROTOCOL (HRP-590)” is required.
● Depending on the nature of what you are doing, some sections may not be
applicable to your research. If so mark as “NA”. For example, research involving a
retrospective chart review may have many sections with N/A.
● Please do not delete sections if they do not apply to the study.
● We suggest that you use the word “participant” or “volunteer” rather than
“subject” throughout your protocol. The reason is that “subject” has the sense of
someone under the authority of the investigator while “participant” or “volunteer”
has the sense of a person who understands and is an important contributor to the
research.
● After you submit your protocol for review in ETHOS, your protocol will be saved
there. You should use that saved version as your starting point for edits to the next
version. You may choose to track protocol versions for yourself outside of ETHOS;
however, you should ensure that any version you edit is the same as the most
recently approved version in ETHOS.
● As you are writing the protocol, remove all instructions in red so that they are not
contained in the final version of your protocol.
● To update page numbers in the Table of Contents, right click on the table and select
“Update Field” and “page numbers only.”
Page 1 of 28 Template Revised On: 06/302022
SOCIAL PROTOCOL (HRP-580)
PROTOCOL TITLE:
VERSION DATE:
ANCILLARY REVIEWS
DO NOT DELETE. Submit the completed checklist below with your protocol.
Which ancillary reviews do I need and when do I need them?
Refer to HRP-309 for more information about these ancillary reviews.
Select yes or Does your study… If yes… Impact on
no IRB Review
☐ Yes Include Gillette resources, staf Gillette Scientific review and Gillette Required
☐ No or locations Research Administration approval is prior to IRB
required. Contact: submission
research@gillettechildrens.com
☐ Yes Involve Epic, or Fairview The Fairview ancillary review will be Approval
☐ No patients, staf, locations, or assigned to your study by IRB staf must be
resources? Contact: ancillaryreview@Fairview.org received
prior to IRB
☐ Yes Include evaluation of drugs, STOP – Complete the Medical Template committee/
☐ No devices, biologics, tobacco, or Protocol (HRP-590) designated
dietary supplements or data review.
subject to FDA inspection?
The regulatory ancillary review will be
assigned to your study by IRB staf Consider
Contact: medreg@umn.edu seeking
approval
See prior to IRB
https://policy.umn.edu/research/indid submission.
e
Require Scientific Review? Not ONLY REQUIRED BIOMEDICAL
sure? See guidance in the RESEARCH REVIEWED BY FULL
Investigator Manual (HRP-103). COMMITTEE
☐ Yes Relate to cancer patients, Complete the CPRC application
☐ No cancer treatments, cancer process.
screening/prevention, or Contact: ccprc@umn.edu
tobacco?
☐ Yes Include the use of radiation? Approval
☐ No (x-ray imaging, Complete the AURPC Human Use from these
radiopharmaceuticals, external Application and follow instructions on committees
beam or brachytherapy) the form for submission to the AURPC must be
Page 2 of 28 Template Revised On: 06/302022
SOCIAL PROTOCOL (HRP-580)
PROTOCOL TITLE:
VERSION DATE:
committee. received
Contact: barmstro@umn.edu prior to IRB
approval;
☐ Yes Use the Center for Magnetic Complete the CMRR pre-IRB ancillary
☐ No Resonance Research (CMRR) review
or MR at Masonic Institute for Contact: ande2445@umn.edu These
the Developing Brain (MIDB) as groups
a study location? each have
☐ Yes Include the use of recombinant STOP – Complete the Medical Template their own
or synthetic nucleic acids, Protocol (HRP-590) application
☐ No process.
toxins, or infectious agents?
☐ Yes Include the use of human fetal STOP – Complete the Medical Template
☐ No tissue, human embryos, or Protocol (HRP-590)
embryonic stem cells?
☐ Yes Include PHI or are you If yes, HIPCO will conduct a review of
requesting a HIPAA waiver? this protocol.
☐ No
Contact: privacy@umn.edu
☐ Yes Plan to use CTSI Monitoring The CTSI monitoring ancillary review Approval
services, and/or have an IND, will be assigned to your study by IRB must be
☐ No staf.
IDE, or designated NSR-IDE by received
the UMN IRB? Please note eligibility criteria here. prior to IRB
Contact: fencl003@umn.edu approval.
☐ Yes Use data from CTSI Best The Information Exchange ancillary
☐ No Practices Integrated review will be assigned to your study
Informatics Core (BPIC) by IRB staf These
groups do
Formerly the AHC Information Contact: bpic@umn.edu not have a
Exchange (AHC-IE)? separate
☐ Yes Use the Biorepository and STOP – Complete the Medical Template application
☐ No Laboratory Services to collect Protocol (HRP-590) process but
tissue for research? additional
information
The BLS ancillary review will be from the
assigned to your study by IRB staf. study team
Contact: Jenny Pham may be
Pham0435@umn.edu required.
☐ Yes Have a PI or study team The CoI ancillary review will be
☐ No member with a conflict of assigned to your study by IRB staf
interest? Contact: becca002@umn.edu
☐ Yes Need to be registered on If you select “No” in ETHOS, the
Page 3 of 28 Template Revised On: 06/302022
SOCIAL PROTOCOL (HRP-580)
PROTOCOL TITLE:
VERSION DATE:
☐ No clinicaltrials.gov? clinicaltrials.gov ancillary review will
be assigned to your study by IRB staf
Contact: fencl003@umn.edu
☐ Yes Require registration in If you select “No” or “I Don’t Know” in Does not
☐ No OnCore? ETHOS, the OnCore ancillary review affect IRB
will be assigned to your study by IRB approval.
staf
Contact: oncore@umn.edu
Page 4 of 28 Template Revised On: 06/302022
no reviews yet
Please Login to review.